BCA
KALA icon

Berman Capital Advisors’s KALA BIO KALA Stock Holding History

Berman Capital Advisors’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$3K Buy
+1
New +$8.63K ﹤0.01% 1590

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Berman Capital Advisors's KALA Position: Q3 2021 in Review

Berman Capital Advisors opened a new position in KALA BIO (KALA) in Q3 2021: 1 share worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #1590 among its holdings.

99 funds tracked by Wall St. Rank hold KALA as of Q3 2021.

  • Berman Capital Advisors held 1 share of KALA BIO worth $3K as of Q3 2021.
  • KALA BIO was a new Berman Capital Advisors position in Q3 2021.
  • KALA BIO made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1590 holding.
  • 99 funds tracked by Wall St. Rank held KALA BIO as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.